AHA: Apixaban Beats Aspirin for Stroke Prevention in A-Fib

More effective for patients with a-fib, prior stroke history, unsuitability for vitamin K antagonists

THURSDAY, Feb. 2 (HealthDay News) -- Apixaban is more effective than aspirin in reducing the risk of repeat stroke and systemic embolism in patients with atrial fibrillation (AF) who are unsuitable for vitamin K antagonists (VKA) therapy, according to a study presented at the American Heart Association's International Stroke Conference, held from Feb. 1 to 3 in New Orleans.

Hans-Christoph Diener, M.D., of the University Hospital Essen in Germany, and colleagues studied 5,599 patients with AF who were randomized to receive apixaban 5 mg twice daily or aspirin (81 to 324 mg/day). Of the participants, 764 had had a prior stroke or transient ischemic attack (TIA). Patients were followed up for a mean duration of 1.1 years.

The researchers found that, in the patients with prior TIA or stroke, among those randomized to apixaban, there were 10 stroke or systemic embolism events (2.46 percent/year) compared with 33 events in those randomized to aspirin (8.27 percent/year) (hazard ratio [HR], 0.29; P < 0.001). There were nine ischemic strokes in the apixaban group and 27 in the aspirin group (2.21 versus 6.27 percent/year; HR, 0.33; P < 0.002). One patient on apixaban and four patients on aspirin suffered a hemorrhagic stroke. Twenty-two patients on apixaban (5.30 percent/year) and 27 on aspirin (6.55 percent/year) died (HR, 0.82; P = 0.50). No statistically significant differences were seen in major bleeds between the groups.

"In patients with AF who had a TIA or stroke and [were] unsuitable for VKA therapy, apixaban reduced the risk of stroke or systemic embolism to [a] larger extent than aspirin," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Pfizer and Bristol-Myers Squibb who jointly developed apixaban.

Abstract No. 3776
More Information

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95

The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95

Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.

Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.

Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events